Related Experiment Video
Updated: Jun 18, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned?
Jeffrey C Weinreb1, Ali K Abu-Alfa
1Department of Diagnostic Radiology, Yale University School of Medicine, New Haven, Connecticut, USA. jeffrey.weinreb@yale.edu
Abstract:
This article addresses two questions about gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF): "Why did it happen" and "What have we learned"? It reviews the events leading to the discovery of an association between NSF and GBCAs. Various factors are elucidated that contributed to the delay between the time when GBCA came into widespread clinical use and a link was made with NSF, including use in renal-compromised patients, high-dose magnetic resonance angiography (MRA), lack of documentation and adequate databases, policy and regulatory changes, and an absence of scientific evidence. The authors conclude that the overriding cause was lack of awareness. J. Magn. Reson. Imaging 2009;30:1236-1239. (c) 2009 Wiley-Liss, Inc.
More Related Videos
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Related Concept Videos
Nephrotic Syndrome I : Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Imaging Studies VII: Vascular Imaging
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Diabetic Nephropathy